分子细胞遗传学市场－全球产业规模、份额、趋势、机会和预测，按应用、技术、产品、最终用途、地区和竞争格局划分，2020-2030年预测

2024年全球分子细胞遗传学市场规模为22.4亿美元，预计2030年将以8.33%的复合年增长率成长至36.2亿美元。分子细胞遗传学整合了分子生物学和细胞遗传学，用于分析染色体结构，主要用于检测与遗传疾病和癌症相关的异常。该市场的成长主要受全球遗传疾病和肿瘤疾病盛行率不断上升的驱动，这促使人们对精准的诊断工具的需求日益增长。此外，对个人化医疗的需求不断增长，而个人化医疗则依赖详细的基因组资讯来制定客製化治疗方案，这也显着推动了市场成长。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球分子细胞遗传学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依应用领域（遗传疾病、肿瘤学、个人化医疗、其他）
  • 依技术分类（比较基因组杂交、FISH、免疫组织化学核型分析）
  • 依产品分类（仪器、耗材、软体及服务）
  • 依最终用途（医院和诊所、学术研究机构、製药和生物技术公司、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美分子细胞遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲分子细胞遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区分子细胞遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲分子细胞遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲分子细胞遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球分子细胞遗传学市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Danaher Corporation
• MetaSystems International
• Agilent Technologies, Inc.
• Abbott Laboratories, Inc.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Oxford Gene Technology IP Limited
• F. Hoffmann-La Roche Ltd
• PerkinElmer Inc.
• BIOVIEW Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Molecular Cytogenetics Market, valued at USD 2.24 Billion in 2024, is projected to experience a CAGR of 8.33% to reach USD 3.62 Billion by 2030. Molecular cytogenetics integrates molecular biology and cytogenetics to analyze chromosome structure, primarily for detecting abnormalities linked to genetic disorders and cancer. This market's expansion is fundamentally driven by the increasing global prevalence of genetic conditions and oncological diseases, necessitating precise diagnostic tools. The growing demand for personalized medicine, which relies on detailed genomic insights for tailored therapies, also significantly propels market growth.

Key Market Drivers

The global molecular cytogenetics market is significantly influenced by the escalating incidence of cancer and genetic disorders worldwide. These pervasive health challenges necessitate highly precise and comprehensive diagnostic tools, directly driving the demand for molecular cytogenetic techniques capable of detecting chromosomal abnormalities and genetic variations. Such advanced diagnostic capabilities are crucial for early detection, accurate prognosis, and effective treatment planning in oncology and inherited conditions.

Key Market Challenges

The high cost of advanced molecular cytogenetics instrumentation and the specialized expertise required for complex testing procedures represent a significant barrier to market expansion. This financial burden restricts the widespread adoption of these sophisticated diagnostic tools, particularly in regions with developing healthcare infrastructures that face challenges with substantial upfront capital investments and ongoing operational expenses. Acquiring and maintaining state-of-the-art equipment, alongside recruiting and retaining highly skilled personnel, places considerable strain on laboratory budgets.

Key Market Trends

The increasing integration of Artificial Intelligence and automation is fundamentally transforming cytogenetic workflows by enhancing efficiency and precision. These advanced systems are designed to streamline labor-intensive processes such as image analysis, karyotyping, and the detection of chromosomal abnormalities, thereby reducing manual error rates and accelerating turnaround times. For instance, according to CAP Today, in December 2024, digital pathology, which encompasses AI and automation in image analysis, reflected approximately 10 percent adoption in clinical laboratories, indicating a gradual but steady integration into diagnostic practices.

Key Market Players

• Danaher Corporation
• MetaSystems International
• Agilent Technologies, Inc.
• Abbott Laboratories, Inc.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Oxford Gene Technology IP Limited
• F. Hoffmann-La Roche Ltd
• PerkinElmer Inc.
• BIOVIEW Ltd.

Report Scope:

In this report, the Global Molecular Cytogenetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Cytogenetics Market, By Application:

• Genetic Disorders
• Oncology
• Personalized Medicine
• Others

Molecular Cytogenetics Market, By Technology:

• Comparative Genomic Hybridization
• FISH
• Immunohistochemistry Karyotyping

Molecular Cytogenetics Market, By Product:

• Instruments
• Consumables
• Software & Services

Molecular Cytogenetics Market, By End use:

• Hospitals & Clinics
• Academic Research Institutes
• Pharmaceutical & Biotech Companies
• Others

Molecular Cytogenetics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Molecular Cytogenetics Market.

Available Customizations:

Global Molecular Cytogenetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Molecular Cytogenetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Genetic Disorders, Oncology, Personalized Medicine, Others)
  • 5.2.2. By Technology (Comparative Genomic Hybridization, FISH, Immunohistochemistry Karyotyping)
  • 5.2.3. By Product (Instruments, Consumables, Software & Services)
  • 5.2.4. By End use (Hospitals & Clinics, Academic Research Institutes, Pharmaceutical & Biotech Companies, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Molecular Cytogenetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Technology
  • 6.2.3. By Product
  • 6.2.4. By End use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Molecular Cytogenetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Product
      • 6.3.1.2.4. By End use
  • 6.3.2. Canada Molecular Cytogenetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Product
      • 6.3.2.2.4. By End use
  • 6.3.3. Mexico Molecular Cytogenetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Product
      • 6.3.3.2.4. By End use

7. Europe Molecular Cytogenetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Technology
  • 7.2.3. By Product
  • 7.2.4. By End use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Molecular Cytogenetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Product
      • 7.3.1.2.4. By End use
  • 7.3.2. France Molecular Cytogenetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Product
      • 7.3.2.2.4. By End use
  • 7.3.3. United Kingdom Molecular Cytogenetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Product
      • 7.3.3.2.4. By End use
  • 7.3.4. Italy Molecular Cytogenetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Product
      • 7.3.4.2.4. By End use
  • 7.3.5. Spain Molecular Cytogenetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Product
      • 7.3.5.2.4. By End use

8. Asia Pacific Molecular Cytogenetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Technology
  • 8.2.3. By Product
  • 8.2.4. By End use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Molecular Cytogenetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Product
      • 8.3.1.2.4. By End use
  • 8.3.2. India Molecular Cytogenetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Product
      • 8.3.2.2.4. By End use
  • 8.3.3. Japan Molecular Cytogenetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Product
      • 8.3.3.2.4. By End use
  • 8.3.4. South Korea Molecular Cytogenetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Product
      • 8.3.4.2.4. By End use
  • 8.3.5. Australia Molecular Cytogenetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Product
      • 8.3.5.2.4. By End use

9. Middle East & Africa Molecular Cytogenetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Technology
  • 9.2.3. By Product
  • 9.2.4. By End use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Molecular Cytogenetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Product
      • 9.3.1.2.4. By End use
  • 9.3.2. UAE Molecular Cytogenetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Product
      • 9.3.2.2.4. By End use
  • 9.3.3. South Africa Molecular Cytogenetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Product
      • 9.3.3.2.4. By End use

10. South America Molecular Cytogenetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Technology
  • 10.2.3. By Product
  • 10.2.4. By End use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Molecular Cytogenetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Product
      • 10.3.1.2.4. By End use
  • 10.3.2. Colombia Molecular Cytogenetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Product
      • 10.3.2.2.4. By End use
  • 10.3.3. Argentina Molecular Cytogenetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Product
      • 10.3.3.2.4. By End use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Molecular Cytogenetics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Danaher Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. MetaSystems International
• 15.3. Agilent Technologies, Inc.
• 15.4. Abbott Laboratories, Inc.
• 15.5. Bio-Rad Laboratories, Inc.
• 15.6. Illumina, Inc.
• 15.7. Oxford Gene Technology IP Limited
• 15.8. F. Hoffmann-La Roche Ltd
• 15.9. PerkinElmer Inc.
• 15.10. BIOVIEW Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer